Molecule intelOpportunity: StrongEssential

Levonorgestrel

43 brands · 21 companies · product forms

ATC: G03AC03, G03AD01 6 DRAP alerts

Opportunity snapshot

Launch attractiveness
66
Market saturation
58
Price room
100
Regulatory risk
90
43
brands
21
companies
Rs 152.87
median price
30
price points
932.13x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 14%

Price room

Across observed sources and strengths
CheapestRs 20.95
MedianRs 152.87
Most expensiveRs 19,528.04
Spread932.13×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 932.13x across 30 trusted points (Rs 20.95-19528.04). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Levonorgestrel — each links to its own medicine page.

Regulatory alerts

Shortage exposureRecall exposurelatest 2026-05-06
RECALL ALERT – DRUG PRODUCTS DECLARED SUBSTANDARD BY CENTRAL DRUGS LABORATORY, KARACHI.
Recall Alert: Drug Product; Famila 150mg Injection (Batch # 083) By Zafa Pharmaceutical La
RECALL ALERT – BATCHES OF ‘TABLET FAMILA 28F’ DECLARED SUBSTANDARD BY CENTRAL DRUGS LABORA
Risk Communication and Awareness Plan of Pharmacovigilance Activities (Edition 01)
Strategic Plan 2026-2030
RECALL ALERT – FAMILA 28F TABLETS (Batch # K159, K196, K197, K198) DECLARED SUBSTANDARD.

Why this score

Launch attractiveness

40% supply-gap(45) + 25% price-variation(100) + 20% low-competition(42) + 15% supply-disruption(100), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

21 canonical companies and 43 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 932.13x across 30 trusted points (Rs 20.95-19528.04). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

6 DRAP alert(s), latest 2026-05-06 incl. recall/safety.

Confidence

Full coverage.

Packaged brief for this strong opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.